Literature DB >> 27335445

The Function of V-ATPases in Cancer.

Laura Stransky1, Kristina Cotter1, Michael Forgac1.   

Abstract

The vacuolar ATPases (V-ATPases) are a family of proton pumps that couple ATP hydrolysis to proton transport into intracellular compartments and across the plasma membrane. They function in a wide array of normal cellular processes, including membrane traffic, protein processing and degradation, and the coupled transport of small molecules, as well as such physiological processes as urinary acidification and bone resorption. The V-ATPases have also been implicated in a number of disease processes, including viral infection, renal disease, and bone resorption defects. This review is focused on the growing evidence for the important role of V-ATPases in cancer. This includes functions in cellular signaling (particularly Wnt, Notch, and mTOR signaling), cancer cell survival in the highly acidic environment of tumors, aiding the development of drug resistance, as well as crucial roles in tumor cell invasion, migration, and metastasis. Of greatest excitement is evidence that at least some tumors express isoforms of V-ATPase subunits whose disruption is not lethal, leading to the possibility of developing anti-cancer therapeutics that selectively target V-ATPases that function in cancer cells.
Copyright © 2016 the American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27335445      PMCID: PMC4982037          DOI: 10.1152/physrev.00035.2015

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  234 in total

1.  Subunit rotation of vacuolar-type proton pumping ATPase: relative rotation of the G and C subunits.

Authors:  Tomoyuki Hirata; Atsuko Iwamoto-Kihara; Ge-Hong Sun-Wada; Toshihide Okajima; Yoh Wada; Masamitsu Futai
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

Review 2.  Plasmalemmal vacuolar-type H+-ATPase in cancer biology.

Authors:  Souad R Sennoune; Defeng Luo; Raul Martínez-Zaguilán
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

3.  Regulated assembly of vacuolar ATPase is increased during cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase/mTOR-dependent pathway.

Authors:  Rachel Liberman; Sarah Bond; Mara G Shainheit; Miguel J Stadecker; Michael Forgac
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

4.  Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.

Authors:  Kristina Cotter; Joseph Capecci; Souad Sennoune; Markus Huss; Martin Maier; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

5.  Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss.

Authors:  E H Stover; K J Borthwick; C Bavalia; N Eady; D M Fritz; N Rungroj; A B S Giersch; C C Morton; P R Axon; I Akil; E A Al-Sabban; D M Baguley; S Bianca; A Bakkaloglu; Z Bircan; D Chauveau; M-J Clermont; A Guala; S A Hulton; H Kroes; G Li Volti; S Mir; H Mocan; A Nayir; S Ozen; J Rodriguez Soriano; S A Sanjad; V Tasic; C M Taylor; R Topaloglu; A N Smith; F E Karet
Journal:  J Med Genet       Date:  2002-11       Impact factor: 6.318

6.  Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion.

Authors:  C Peters; M J Bayer; S Bühler; J S Andersen; M Mann; A Mayer
Journal:  Nature       Date:  2001-02-01       Impact factor: 49.962

7.  Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance.

Authors:  T Murakami; I Shibuya; T Ise; Z S Chen; S Akiyama; M Nakagawa; H Izumi; T Nakamura; K Matsuo ; Y Yamada; K Kohno
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

8.  Enhanced lysosomal activity is involved in Bax inhibitor-1-induced regulation of the endoplasmic reticulum (ER) stress response and cell death against ER stress: involvement of vacuolar H+-ATPase (V-ATPase).

Authors:  Geum-Hwa Lee; Do-Sung Kim; Hyung-Tae Kim; Jung-Wook Lee; Chin-Ha Chung; Taeho Ahn; Jung Min Lim; In-Ki Kim; Han-Jung Chae; Hyung-Ryong Kim
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

9.  Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma.

Authors:  Jingyu Xu; Rui Xie; Xuemei Liu; Guorong Wen; Hai Jin; Zhihao Yu; Yixia Jiang; Zhenglan Zhao; Yuan Yang; Bei Ji; Hui Dong; Biguang Tuo
Journal:  Carcinogenesis       Date:  2012-09-07       Impact factor: 4.944

10.  Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.

Authors:  Husam A J Alwan; Everardus J J van Zoelen; Jeroen E M van Leeuwen
Journal:  J Biol Chem       Date:  2003-06-26       Impact factor: 5.157

View more
  79 in total

1.  The constitutive protease release by primary human acute myeloid leukemia cells.

Authors:  Maria Honnemyr; Øystein Bruserud; Annette K Brenner
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-19       Impact factor: 4.553

2.  Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness.

Authors:  Joshua C Snyder; Lauren K Rochelle; Caroline Ray; Thomas F Pack; Cheryl B Bock; Veronica Lubkov; H Kim Lyerly; Alan S Waggoner; Larry S Barak; Marc G Caron
Journal:  J Biol Chem       Date:  2017-03-08       Impact factor: 5.157

3.  Interaction of the late endo-lysosomal lipid PI(3,5)P2 with the Vph1 isoform of yeast V-ATPase increases its activity and cellular stress tolerance.

Authors:  Subhrajit Banerjee; Kaitlyn Clapp; Maureen Tarsio; Patricia M Kane
Journal:  J Biol Chem       Date:  2019-04-25       Impact factor: 5.157

4.  V-ATPase blockade reduces renal gluconeogenesis and improves insulin secretion in type 2 diabetic rats.

Authors:  Jun Hirao; Akihiro Tojo; Saaya Hatakeyama; Hiroshi Satonaka; Toshihiko Ishimitsu
Journal:  Hypertens Res       Date:  2020-05-08       Impact factor: 3.872

5.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  Lgl reduces endosomal vesicle acidification and Notch signaling by promoting the interaction between Vap33 and the V-ATPase complex.

Authors:  Marta Portela; Liu Yang; Sayantanee Paul; Xia Li; Alexey Veraksa; Linda M Parsons; Helena E Richardson
Journal:  Sci Signal       Date:  2018-06-05       Impact factor: 8.192

7.  Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma.

Authors:  Sahar K Hegazy; Sahar M El-Haggar; Suzan A Alhassanin; Eman I El-Berri
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

8.  Structural comparison of the vacuolar and Golgi V-ATPases from Saccharomyces cerevisiae.

Authors:  Thamiya Vasanthakumar; Stephanie A Bueler; Di Wu; Victoria Beilsten-Edmands; Carol V Robinson; John L Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

9.  Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo.

Authors:  King Faisal Yambire; Christine Rostosky; Takashi Watanabe; David Pacheu-Grau; Sylvia Torres-Odio; Angela Sanchez-Guerrero; Ola Senderovich; Esther G Meyron-Holtz; Ira Milosevic; Jens Frahm; A Phillip West; Nuno Raimundo
Journal:  Elife       Date:  2019-12-03       Impact factor: 8.140

10.  Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition.

Authors:  Alexandria N Young; Denisse Herrera; Andrew C Huntsman; Melissa A Korkmaz; Daniel D Lantvit; Sarmistha Mazumder; Shamalatha Kolli; Christopher C Coss; Salane King; Hongyan Wang; Steven M Swanson; A Douglas Kinghorn; Xiaoli Zhang; Mitch A Phelps; Leslie N Aldrich; James R Fuchs; Joanna E Burdette
Journal:  Mol Cancer Ther       Date:  2018-07-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.